@FiercePharma: Perrigo sees growth, but its sales are trimmed by a hit to contract manufacturing. Story | Follow @FiercePharma
@TracyStaton: Double dose of Merck is too much for German version's CEO. Article | Follow @TracyStaton
@EricPFierce: The best biomedical research facilities in the US may not surprise you. Then again maybe it will. Report | Follow @EricPFierce
@GalenMoore: Particularly for drugmakers strong in diabetes, the Gulf region is a hotbed of activity. Story | Follow @GalenMoore
> Arena Pharmaceuticals ($ARNA) and its marketing partner, Eisai, said they made a deal with the pharmacy benefits manager CVS Caremark ($CVS) to make their weight-loss drug Belviq available to members. Report
> Israel-based Teva Pharmaceutical Industries ($TEVA) Chairman Phillip Frost sold shares worth $7 million, leaving him a stake of $500 million-plus. Report
> The Swiss drugmaker Actelion hiked its dividend by 20% after sales of its new drug, Opsumit, rose. Report
> Top executives from more than a dozen Indian drugmakers met with FDA Commissioner Margaret Hamburg in New Delhi to talk about manufacturing problems and agency oversight. Report
> Innovus Pharma tapped Lynnette Dillen to join the company as EVP and CFO. Release
> India's Aurobindo Pharma said its profit tripled for its fiscal third quarter. Report
@FierceMedDev: St. Jude Medical's stock spiked again after an analyst upgrade. Story | Follow @FierceMedDev
@MarkHFierce: FierceBiotechResearch's latest--a look at the top 10 U.S. biomedical research institutions. Report | Follow @MarkHFierce
@MichaelGFierce: Sonrgy grabs rights to UCSD-created ultrasound-nanocarrier tech. Item from FierceDrugDelivery | Follow @MichaelGFierce
@EmilyWFierce: ConvaTec is closing its New Jersey facility and cutting jobs. Story | Follow @EmilyWFierce
> Two major Dx players in Brazil are on the cusp of major changes. Item
> Surgeons have implanted a 3-D-printed pelvis into a U.K. cancer patient. More
> Smiths Medical adds tracheostomy tubes designed for kids to standard product line. News
Biotech News
@FierceBiotech: Another 5 biotechs are queuing up for $278M in IPOs. Is this a bubble after all? More | Follow @FierceBiotech
@JohnCFierce: I'm happy to see the IPO boom, the rise in valuations and all that. But with booms, the bigger they are, the harder they fall. Don't forget. | Follow @JohnCFierce
@DamianFierce: The FDA is giving Sprout's female libido drug another shot in what is becoming a pretty interesting case study. Coverage | Follow @DamianFierce
@EmilyMFierce: The top 10 biomedical research organizations, ranked by NIH funding. Special report | Follow @EmilyMFierce
> The world's two Mercks squabble over who gets to be a household name. Story
> GlaxoSmithKline R&D chief touts the future of 'electroceuticals.' News
Biotech Research News
> The top 10 biomedical research institutions. Special Report
> CalTech drug delivery method halts HIV infection in mice. Article
> Nasal vaccine protects mice from West Nile virus. Story
> U.K. pledges to reduce use of animals for biomedical research. News
> Gates Foundation delivers an $11.8M grant to fuel tuberculosis R&D. Story
> New therapeutic target for multiple sclerosis could help repair damaged brain cells. Article
Pharma Manufacturing News
> FDA says products recalled by compounder are contaminated. News
> Teva, which has been tightening its supply chain, turns in a surprising financial report. Story
> Jazz is investing up to $68M to build its first manufacturing facility. Article
> Wockhardt's earnings crash under the weight of FDA bans. News
> The FDA reports far fewer new drug shortages, but the problem continues to grow. Article
> Novartis is expanding a plant in Singapore. Item
And Finally... Will Switzerland's new immigration limits force out expat execs? Report